Homepage | PCR Diagnostics

PCR Diagnostics products

DIANA Biotechnologies has developed a series of ultra-sensitive PCR-based diagnostic tests to fight the COVID-19 epidemic. These are optimized to be run in diagnostic labs in high-throughput format. Our COVID-19 tests are currently in use at over 30 clinical laboratories in the Czech Republic and also being exported abroad. We have already produced more than 6 milion COVID-19 tests, covering 40 % of czech testing capacity.
In January 2021 we have introduced to the market our novel technology DBdirect, allowing PCR detection directly from clinical samples (both nasopharyngeal swabs and saliva) without the need of prior isolation of RNA. DBdirect based saliva tests can in our view revolutionize the COVID-19 testing, combining ultra-sensitive detection with the easy self-collection of the samples. These tests are suitable both for clinical diagnostics (CE IVD mark) and preventive screening programs.
Untitled design (1)